Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shulman

Showing results (141-150 of 282) with videos related to

Pageof 29
Sort By:
Investigational New Drugs|March 9, 2007
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactionsNancy U Lin, Leroy M Parker, Steven E Come, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Clinical presentation and outcome in lymphocyte-predominant Hodgkin's diseaseS Bodis, M D Kraus, G Pinkus, et al.
Cancer|October 26, 2005
Medication safety in the ambulatory chemotherapy settingTejal K Gandhi, Sylvia B Bartel, Lawrence N Shulman, et al.
American Journal of Clinical Pathology|September 21, 2014
Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settingsTharcisse Mpunga, Neo Tapela, Bethany L Hedt-Gauthier, et al.
JCO Global Oncology|October 24, 2024
Barriers to Implementing a Quality Improvement Program in Low- and Middle-Income Countries: Adequacy of ResourcesDebanjan Pain, Emily MacDuffie, Yehoda M Martei, et al.
Annals of Surgical Oncology|March 31, 2019
Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer ResectionsLawrence N Shulman, Amanda E Browner, Bryan E Palis, et al.
Journal of the National Cancer Institute|April 26, 2020
Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research PrioritiesCorinne R Leach, Catherine M Alfano, Jessica Potts, et al.
The Oncologist|August 14, 2021
Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research AnalysisTlotlo Ralefala, Lebogang Mokokwe, Swetha Jammalamadugu, et al.
Transfusion|October 1, 1995
The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy supportR J Benjamin, L Linsley, J D Axelrod, et al.
Journal of the National Cancer Institute|September 21, 2022
Addressing Transportation Insecurity Among Patients With CancerEvan M Graboyes, Krisda H Chaiyachati, Jennifer Sisto Gall, et al.
Pageof 29

Showing results (141-150 of 282) with videos related to

Sort By:
Pageof 29
Investigational New Drugs|March 9, 2007
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactionsNancy U Lin, Leroy M Parker, Steven E Come, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Clinical presentation and outcome in lymphocyte-predominant Hodgkin's diseaseS Bodis, M D Kraus, G Pinkus, et al.
Cancer|October 26, 2005
Medication safety in the ambulatory chemotherapy settingTejal K Gandhi, Sylvia B Bartel, Lawrence N Shulman, et al.
American Journal of Clinical Pathology|September 21, 2014
Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settingsTharcisse Mpunga, Neo Tapela, Bethany L Hedt-Gauthier, et al.
JCO Global Oncology|October 24, 2024
Barriers to Implementing a Quality Improvement Program in Low- and Middle-Income Countries: Adequacy of ResourcesDebanjan Pain, Emily MacDuffie, Yehoda M Martei, et al.
Annals of Surgical Oncology|March 31, 2019
Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer ResectionsLawrence N Shulman, Amanda E Browner, Bryan E Palis, et al.
Journal of the National Cancer Institute|April 26, 2020
Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research PrioritiesCorinne R Leach, Catherine M Alfano, Jessica Potts, et al.
The Oncologist|August 14, 2021
Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research AnalysisTlotlo Ralefala, Lebogang Mokokwe, Swetha Jammalamadugu, et al.
Transfusion|October 1, 1995
The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy supportR J Benjamin, L Linsley, J D Axelrod, et al.
Journal of the National Cancer Institute|September 21, 2022
Addressing Transportation Insecurity Among Patients With CancerEvan M Graboyes, Krisda H Chaiyachati, Jennifer Sisto Gall, et al.
Pageof 29